SCHEMBL26557342

SCHEMBL26557342

c1ccc(-c2cccc(N(c3ccc(-c4cccc5cccc(-c6ccccc6)c45)cc3)c3ccc4cc5oc6ccccc6c5cc4c3)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.33
▸ PLA2G2A P14555 3/20 0.32
▸ PLA2G4A P47712 3/20 0.32
▸ AHR P35869 1/20 0.32
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ SENP7 Q9BQF6 1/20 0.31
▸ SENP6 Q9GZR1 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ MMP12 P39900 1/20 0.30
▸ MMP13 P45452 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26557333 0.91 PIM1 (0.33) HCRTR1PLA2G2APLA2G4ACASP3SENP7
SCHEMBL24361680 0.90 GPR84 (0.33) HCRTR1PLA2G2APLA2G4AAHRMMP12
SCHEMBL24658225 0.89 KDM4E (0.33) PLA2G2APLA2G4AAHRKDM4EALDH1A1
SCHEMBL26557343 0.89 AHR (0.31) AHRALOX5
SCHEMBL24656589 0.89 CYP1A1 (0.33) HCRTR1AHRCDK4CCND1CA12
SCHEMBL26061586 0.89 KDM4E (0.32) HCRTR1AHRALOX5KDM4EALDH1A1
SCHEMBL26325068 0.89 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4AAHRCASP3
SCHEMBL24901119 0.88 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AAHRALOX5
SCHEMBL24901316 0.88 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AAHRALOX5
SCHEMBL24658166 0.88 TDP1 (0.34) HCRTR1AHRCDK4CCND1MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322656-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-12 — — US disclosed
US-20230322656-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322656-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME PIEZO1, OR10J3, ODC1 HCRTR1 3456/4885PLA2G2A 4767/4885PLA2G4A 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback